Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-005327-16Phase 4Completed
Phase 4, randomised, open-label trial of oxycodone + naloxone and oxycodone in postoperative pain (2 arms), sponsored by University of Edinburgh. Primary endpoint: Reduction in gut dysfunction by programmed day of discharge. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-005327-16.